Visiongain Report Claims There is Huge Potential Within the $141bn Anti-Infective Agents Market

Anti-infective Agents Market Forecast 2019-2029

Anti-viral Infections, Anti-bacterial Infections, Anti-fungal Infections, Hepatitis Virus Infection, HIV Infection, Pneumonia, Aspergillosis, Methicillin-resistant Staphylococcus Aureus (MRSA), Dermatophytosis, Tuberculosis, Respiratory Virus Infection, Sepsis, Hospital Pharmacies, Retail Pharmacies, Online Sales

News provided by

Visiongain

Nov 05, 2019, 05:00 ET

LONDON, Nov. 5, 2019 /PRNewswire/ -- The global anti-infective agents market is estimated to have reached $109bn in 2018 and is expected to grow at a CAGR of 4.2% during the forecast period. In 2018, the hospital pharmacy segment dominated the distribution channel of the anti-infective agents market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 154-page report you will receive 127 charts– all unavailable elsewhere.

The 154-page Visiongain report provides clear detailed insight into the anti-infective agents market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

To request sample pages from this report please contact Sara Peerun at [email protected] or refer to our website: https://www.visiongain.com/report/anti-infective-agents-market-report-2019-2029/#download_sampe_div

• Global Anti-infective Agents Market forecasts from 2019-2029

• Global Anti-infective Agents Market forecasts from 2019-2029 by Type:
• Antiviral infections
• Antibacterial infections: B-Lactams, Quinolones, Macrolides, Tetracycline, Aminoglycoside
• Antifungal infections: Azoles, Echinocandins, Polyenes

• Global Anti-infective Agents Market forecasts from 2019-2029 by Indication:
• Hepatitis Virus Infection
• HIV Infection
• Pneumonia
• Aspergillosis
• Methicillin-resistant Staphylococcus Aureus (MRSA)
• Dermatophytosis
• Tuberculosis
• Respiratory Virus Infection
• Sepsis

• Global Anti-infective Agents Market forecasts from 2019-2029 by Distribution Channel:
• Hospital Pharmacies
• Retail Pharmacies
• Online Sales

• Global Anti-infective Agents Market forecasts from 2019-2029 by regional and national market:
• North America (US, Canada)
• Europe (Germany, UK, France, Rest of Europe)
• Asia Pacific (Japan, China, India, Rest of APAC)
• RoW (Latin America, Middle East and Africa)

• Profiles of the selected leading companies:
• Abbott Laboratories
• Bristol-Myers Squibb
• GlaxoSmithKline (GSK)
• Merck & Co.
• Novartis AG
• Sanofi SA
• Pfizer

• Anti-infective agents R&D Pipeline

• Key Questions Answered by this Report:
• How is the Anti-infective Agents market evolving?
• What is driving and restraining the Anti-infective Agents market dynamics?
• How will each of the submarkets grow over the forecast period and how much revenue will these submarkets account for in 2029?
• How will the market shares for each of the Anti-infective Agents submarkets develop from 2019 to 2029?
• What will be the main driver for the overall market from 2019-2029?
• How will political and regulatory factors influence the regional markets and submarkets?
• How will the market shares of the national markets change by 2029 and which geographical region will lead the market in 2029?
• Who are the leading players and what are their prospects over the forecast period?
• How will the industry sector evolve during the period between 2019 and 2029?

To request a report overview of this report please contact Sara Peerun at [email protected] or refer to our website: https://www.visiongain.com/report/anti-infective-agents-market-report-2019-2029/

Did you know that we also offer a report add-on service? Email [email protected] to discuss any customized research needs you may have.

Companies covered in the report include:

Abbott Laboratories
Allergan
Amplyx Pharmaceuticals
Arno Therapeutics
AureoGen Biosciences
Bristol-Myers Squibb
Celgene Corporation
Centers for Disease Control (CDC)
Cidara Therapeutics
Committee for Medicinal Products for Human Use (CHMP)
European Commission (EC)
European Medicines Agency (EMA)
Food and Drug Administration (FDA)
GlaxoSmithKline (GSK)
InnoPharma
Merck & Co., Inc.
Mirati Therapeutics
Novartis AG
Pfizer
Sanofi SA
Roche
Tokuyama Corporation
Vical
World Health Organization (WHO)